German pharmaceutical manufacturers fear new American tariffs
Share:
German pharmaceutical companies are expressing concerns about potential new tariffs from the United States, according to industry representatives. The pressure from the US is causing companies to reassess their investment plans in Germany, said Han Steutel, president of VFA, the association representing research-based pharmaceutical companies in Germany. The uncertainty over trade policy is prompting manufacturers to reconsider their strategic investments in German operations.